Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Marken

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Pharmacy|June 1, 1992
Criteria for use of agents for extrapyramidal adverse effects in adult, adolescent, and child inpatients and outpatientsP A Marken, J R Ezell
Clinical Pharmacy|August 1, 1993
Criteria for use of lithium in adult inpatients and outpatientsP A Marken, J R Ezell
Journal of Clinical Pharmacology|April 1, 1994
An atypical course of neuroleptic malignant syndromeM E Schneiderhan, P A Marken
DICP : the Annals of Pharmacotherapy|July 1, 1989
Bromocriptine in treatment of depressionB G Wells, P A Marken
DICP : the Annals of Pharmacotherapy|July 1, 1991
Pharmacologic treatment of cocaine abuseS Lacombe, S W Stanislav, P A Marken
Clinical Pharmacy|October 1, 1992
Management of psychotropic-induced hyperprolactinemiaP A Marken, R F Haykal, J N Fisher
The Annals of Pharmacotherapy|June 14, 2000
Clozapine-associated extrapyramidal reactionE S Elliott, P A Marken, V L Ruehter
DICP : the Annals of Pharmacotherapy|July 1, 1989
Treatment of psychosis in pregnancyP A Marken, B G Wells, C S Brown
Journal of Child and Adolescent Psychopharmacology|April 1, 1997
Attenuation of antipsychotic-induced hyperprolactinemia with clozapineM T Bunker, P A Marken, M E Schneiderhan, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 16, 2000
Atypical antipsychotic agents: a critical reviewJ A Worrel, P A Marken, S E Beckman, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Pharmacy|June 1, 1992
Criteria for use of agents for extrapyramidal adverse effects in adult, adolescent, and child inpatients and outpatientsP A Marken, J R Ezell
Clinical Pharmacy|August 1, 1993
Criteria for use of lithium in adult inpatients and outpatientsP A Marken, J R Ezell
Journal of Clinical Pharmacology|April 1, 1994
An atypical course of neuroleptic malignant syndromeM E Schneiderhan, P A Marken
DICP : the Annals of Pharmacotherapy|July 1, 1989
Bromocriptine in treatment of depressionB G Wells, P A Marken
DICP : the Annals of Pharmacotherapy|July 1, 1991
Pharmacologic treatment of cocaine abuseS Lacombe, S W Stanislav, P A Marken
Clinical Pharmacy|October 1, 1992
Management of psychotropic-induced hyperprolactinemiaP A Marken, R F Haykal, J N Fisher
The Annals of Pharmacotherapy|June 14, 2000
Clozapine-associated extrapyramidal reactionE S Elliott, P A Marken, V L Ruehter
DICP : the Annals of Pharmacotherapy|July 1, 1989
Treatment of psychosis in pregnancyP A Marken, B G Wells, C S Brown
Journal of Child and Adolescent Psychopharmacology|April 1, 1997
Attenuation of antipsychotic-induced hyperprolactinemia with clozapineM T Bunker, P A Marken, M E Schneiderhan, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 16, 2000
Atypical antipsychotic agents: a critical reviewJ A Worrel, P A Marken, S E Beckman, et al.
Pageof 3